By Michael Macagnone ( May 5, 2016, 8:02 PM EDT) -- The Patent Trial and Appeal Board on Tuesday effectively nixed the remaining claims of SoberLink's patent for a device to test blood alcohol content, ruling the company's latest motion to amend its patent claims had not distinguished its invention from existing blood alcohol monitors....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.